Belgium· BE-AMP-SAM600720-00
Bortezomib EG 2.5 mg/ml
A bortezomib product containing bortezomib mannitol boronic ester, registered in Belgium by EG. The same ATC class is registered in 15 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Bortezomib is registered in 15 of 19 countries.
Countries holding a registration under ATC L01XG01 (bortezomib), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Bortezomib · ATC L01XG01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bortezomib costs, country by country.
Normalised to the WHO defined daily dose (0.45 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bortezomib · price per daily dose (0.45 mg)
USD · FX 28 Sept 2026
- CH Switzerland$66.46
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Bortezomib Mannitol Boronic Ester
- Manufacturer
- EG
- Country
- Belgium (BE)
- ATC code
- L01XG01
- ATC class
- Bortezomib
- Defined daily dose
- 0.45 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
587 interactions on record for bortezomib.
Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bortezomib · interactions on record
587 records
- 45 severe
- 250 moderate
- 66 minor
- 226 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- RifampicinJ04AB02severe
- RifabutinJ04AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bortezomib in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/14df6ca4-756b-48a4-81bf-9b7c61d75602 GET /v1/drugs/14df6ca4-756b-48a4-81bf-9b7c61d75602?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Bortezomib EG 2.5 mg/ml",
"name_fr": "Bortezomib EG 2.5 mg/ml",
"name_nl": "Bortezomib EG 2.5 mg/ml",
"amp_code": "SAM600720-00",
"strengths": [
"2.5000",
"25.0000",
"9.0000"
],
"pack_count": 1,
"substances": [
"Bortezomib Mannitol Boronic Ester",
"Bortezomib",
"Mannitol",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Bortezomib",
"authorisation_numbers": [
"BE600720"
]
}See everything about bortezomib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.